Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases
2014 · British Journal of Cancer · 44 citations
https://doi.org/10.1038/bjc.2014.595
H
Hiroshi Sonoue
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
31
Papers
770
Citations
14
h-index
16
i10-index
Hiroshi Sonoue is an academic researcher from Juntendo University. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & HER2/EGFR in Cancer Research & Endometrial and Cervical Cancer Treatments. The author has an h-index of 14, co-authored 27 publications.
Papers by this author
worksMonoclonal antibody to HER-2/neu receptor enhances radiosensitivity of esophageal cancer cell lines expressing HER-2/neu oncoprotein
2004 · International Journal of Radiation Oncology*Biology*Physics · 42 citations
https://doi.org/10.1016/j.ijrobp.2004.05.017
Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer
2014 · BMC Cancer · 27 citations
https://doi.org/10.1186/1471-2407-14-550
Prognostic significance of the infiltrative pattern invasion in endometrioid adenocarcinoma of the endometrium
2003 · Pathology International · 25 citations
https://doi.org/10.1046/j.1440-1827.2003.01509.x
Elucidation of inhibitory effects on metastatic sentinel lymph nodes of breast cancer during One-Step Nucleic Acid Amplification
2018 · Scientific Reports · 5 citations
https://doi.org/10.1038/s41598-018-25911-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat